Cargando…

Severe food allergy in children. Omalizumab as an alternative treatment to elimination diet

Detalles Bibliográficos
Autores principales:	Pena Peloche, María, Macías, Miguel Hinojosa, Cepeda, Soledad Terrados, Gimeno, Pilar Berges, Sánchez Moreno, Gema Vanesa, Álvarez-Cuesta, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354186/ http://dx.doi.org/10.1186/2045-7022-1-S1-P55

Ejemplares similares

Rhinitis induced to mace
por: Sanchez Moreno, Gema Vanesa, et al.
Publicado: (2011)

Efficacy of omalizumab in reducing latex allergy
por: Aruanno, Arianna, et al.
Publicado: (2021)

P95 - Cow’s milk allergy with tolerance to sterilised cow’s milk. A case report
por: Villafana, Liseth, et al.
Publicado: (2014)

Omalizumab as successful treatment option in severe peanut allergy
por: Dehlink, E, et al.
Publicado: (2013)

Treatment of severe cow’s milk allergy with omalizumab in an adult
por: Klein, Benjamin, et al.
Publicado: (2023)

Safe Handling of Antineoplastic Drugs During Allergy Diagnostic Workup and Desensitization: A Single Experience of the Allergy Department in a Tertiary Hospital
por: Berges-Gimeno, María Pilar, et al.
Publicado: (2022)

Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy
por: Meucci, Elisa, et al.
Publicado: (2021)

Allergy to Omalizumab: Lessons from a Reaction to the Coronavirus 2019 Vaccine
por: Matsumoto, Takeshi, et al.
Publicado: (2023)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Efficacy of long-term treatment with omalizumab in a food and inhalant allergy patient
por: Nucera, Eleonora, et al.
Publicado: (2020)

Oral tolerance induction with heated egg in childrena and adolescents
por: Villafana, L, et al.
Publicado: (2013)

Successful management of severe cow's milk allergy with omalizumab treatment and CD-sens monitoring
por: Nilsson, Caroline, et al.
Publicado: (2014)

Successful treatment of a patient with adult food allergy and severe asthma using omalizumab
por: Nishie, Miyuki, et al.
Publicado: (2021)

Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy
por: Badina, Laura, et al.
Publicado: (2021)

Successful Use of Omalizumab in an Inadequately Controlled Type 2 Diabetic Patient With Severe Insulin Allergy
por: Cavelti-Weder, Claudia, et al.
Publicado: (2012)

Performance of component resolved microarray diagnosis in fruits allergy
por: Goikoetxea, María José, et al.
Publicado: (2015)

Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)

Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2017)

LTP Allergy Follow-Up Study: Development of Allergy to New Plant Foods 10 Years Later
por: Betancor, Diana, et al.
Publicado: (2021)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Changes in antigen-specific T cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab
por: Bedoret, D, et al.
Publicado: (2012)

The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)

Omalizumab—A Review
por: Godse, Kiran, et al.
Publicado: (2015)

360 Effects of Omalizumab in Children with Atopic Keratocojunctivitis: A New Treatment for Severe Ocular Allergies?—Report of Two Cases
por: Kuschnir, Fábio, et al.
Publicado: (2012)

Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2018)

Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)
por: Wood, Robert A., et al.
Publicado: (2022)

Prefabricación ligera de viviendas : nuevas premisas /
por: Terrados Cepeda, F. Javier
Publicado: (2012)

Omalizumab an effective and safe alternative therapy in severe refractory atopic dermatitis: A case report
por: Sirufo, Maria Maddalena, et al.
Publicado: (2018)

Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy
por: Takahashi, Masaya, et al.
Publicado: (2015)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Sex, Allergic Diseases and Omalizumab
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Alleviation of Peanut Allergy Through Nambudripad's Allergy Elimination Techniques (NAET): A Case Report
por: Nambudripad, Roy
Publicado: (2014)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Treatment of estrogen-induced dermatitis with omalizumab
por: Ocana, Jesus A., et al.
Publicado: (2019)

Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019)

Monitoring of omalizumab therapy in children and adolescents
por: Steiß, J.O., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f1l230iqbbjl3s8lfo781iudue